Pscherer, S <br/><br/>
Comparison of one-year costs of type 2 diabetes treatment with insulin glargine or insulin detemir in a basal supported oral therapy (BOT) in Germany.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Feb 2010 
 - 129-37 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/cpp48129  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Germany<br/>Health Care Costs<br/>Humans<br/>Hypoglycemic Agents--economics<br/>Insulin--analogs & derivatives<br/>Insulin Detemir<br/>Insulin Glargine<br/>Insulin, Long-Acting<br/>Randomized Controlled Trials as Topic<br/>Reagent Strips--economics<br/>Syringes--economics